BioCentury
ARTICLE | Company News

Qiagen sales and marketing update

December 7, 2016 10:30 PM UTC

Qiagen launched its ipsogen CALR RGQ PCR Kit in Europe to aid in diagnosis of myeloproliferative neoplasms. The real-time PCR assay detects Type I and I calreticulin (CALR) mutations and mutations in ...

BCIQ Company Profiles

Qiagen N.V.

BCIQ Target Profiles

Calreticulin (CALR)